Agilis Biotherapeutics
Cambridge, US · Founded 2013 · Delaware corporation · 1 known investors
Founders & leadership
Agilis Biotherapeutics was founded in 2013 by G. Houston Hall and Adrian Z. Stecyk.
GH
G. Houston HallManager of the Issuer
AZ
Adrian Z. StecykManager of the Issuer
MJ
Mark J. PykettManager of the Issuer
Board
AM
Alexander M. SeaverManager of the Issuer
AT
Investors · 1
Reported raises · per SEC filings
Form D private placements$20.7M disclosed across 2 of 3 rounds · 2013–2017
▶$12.7MraisedFeb 2017 · 19 investors · BiotechnologyRule 506(b)
▶$12.7MraisedFeb 2017 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark J. PykettExecutive Officer, Director
- Alexander M. SeaverDirector
- Robert HardieDirector
- Adrian Z. StecykDirector
- G. Houston HallDirector
- Ian RatcliffeDirector
- Offering amount
- $23.3M
- Amount sold
- $12.7M
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$5MofferedFeb 2016 · BiotechnologyRule 506(b)
▶$5MofferedFeb 2016 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alexander M. SeaverDirector
- G. Houston HallDirector
- Adrian Z. StecykDirector
- Mark J. PykettDirector
- Arthur TzianabosDirector
- Offering amount
- $5M
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$8MraisedJan 2014 · 27 investors · BiotechnologyRule 506(b)
▶$8MraisedJan 2014 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- G. Houston HallExecutive Officer
- Alexander M. SeaverExecutive Officer
- Adrian Z. StecykExecutive Officer
- Amount sold
- $8M
- First sale
- Dec 2013
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Agilis Biotherapeutics?
- Agilis Biotherapeutics was founded by G. Houston Hall, Adrian Z. Stecyk in 2013.
- Who are Agilis Biotherapeutics's investors?
- Agilis Biotherapeutics's investors include 5AM Ventures.
- How much funding has Agilis Biotherapeutics raised?
- Agilis Biotherapeutics has disclosed $20.7M raised across 2 of its 3 known rounds.
- Where is Agilis Biotherapeutics headquartered?
- Agilis Biotherapeutics is headquartered in Cambridge, US.